Evidence map›Paper›PMID 37237822›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Employing Gamma-Ray-Modified Carbon Quantum Dots to Combat a Wide Range of Bacteria.

Zoran M Marković, Aleksandra S Mišović, Danica Z Zmejkoski, Nemanja M Zdravković, Janez Kovač, Danica V Bajuk-Bogdanović, Dušan D Milivojević, Marija M Mojsin, Milena J Stevanović, Vladimir B Pavlović and 1 more

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Carbon dots derived fromFrontiers in molecular biosciences · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zoran M MarkovićVinča Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, Mike Alasa 12-14, 11001 Belgrade, Serbia.ORCID 0000-0001-5917-4337
Aleksandra S MišovićVinča Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, Mike Alasa 12-14, 11001 Belgrade, Serbia.
Danica Z ZmejkoskiVinča Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, Mike Alasa 12-14, 11001 Belgrade, Serbia.
Nemanja M ZdravkovićScientific Veterinary Institute of Serbia, Janisa Janulisa 14, 11107 Belgrade, Serbia.ORCID 0000-0002-3925-4409
Janez KovačJozef Stefan Institute, Department of Surface Engineering-F4, Jamova cesta 39, 1000 Ljubljana, Slovenia.ORCID 0000-0002-4324-246X
Danica V Bajuk-BogdanovićFaculty of Physical Chemistry, University of Belgrade, Studentski trg 12-16, 11158 Belgrade, Serbia.ORCID 0000-0003-2443-376X
Dušan D MilivojevićVinča Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, Mike Alasa 12-14, 11001 Belgrade, Serbia.ORCID 0000-0001-8924-2679
Marija M MojsinInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia.ORCID 0000-0001-8775-0522
Milena J StevanovićInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia.ORCID 0000-0003-4286-7334
Vladimir B PavlovićFaculty of Agriculture, University of Belgrade, Nemanjina 6, Zemun, 11080 Belgrade, Serbia.
Biljana M Todorović MarkovićVinča Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, Mike Alasa 12-14, 11001 Belgrade, Serbia.ORCID 0000-0002-0704-4327

Funding

Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-47/2023-01/ 200017
6 · The paper itself

Abstract

Nowadays, it is a great challenge to develop new medicines for treating various infectious diseases. The treatment of these diseases is of utmost interest to further prevent the development of multi-drug resistance in different pathogens. Carbon quantum dots, as a new member of the carbon nanomaterials family, can potentially be used as a highly promising visible-light-triggered antibacterial agent. In this work, the results of antibacterial and cytotoxic activities of gamma-ray-irradiated carbon quantum dots are presented. Carbon quantum dots (CQDs) were synthesized from citric acid by a pyrolysis procedure and irradiated by gamma rays at different doses (25, 50, 100 and 200 kGy). Structure, chemical composition and optical properties were investigated by atomic force microscopy, transmission electron microscopy, X-ray photoelectron spectroscopy, Fourier transform infrared spectroscopy, Raman spectroscopy, UV-Vis spectrometry and photoluminescence. Structural analysis showed that CQDs have a spherical-like shape and dose-dependent average diameters and heights. Antibacterial tests showed that all irradiated dots had antibacterial activity but CQDs irradiated with dose of 100 kGy had antibacterial activity against all seven pathogen-reference bacterial strains. Gamma-ray-modified CQDs did not show any cytotoxicity toward human fetal-originated MRC-5 cells. Moreover, fluorescence microscopy showed excellent cellular uptake of CQDs irradiated with doses of 25 and 200 kGy into MRC-5 cells.

Indexed as

antibacterial activitycarbon quantum dotscellular uptakegamma rays

Identifiers

PMID37237822
PMCPMC10215299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.